← Back to Search

Supportive Care for Young Adult Cancer Survivors

N/A

Recruiting

Led By K. Scott Baker

Research Sponsored by Fred Hutchinson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Received a therapeutic intervention (with curative intent if advanced stage disease) that included any of the following modalities: surgery, cytotoxic chemotherapy, biological or targeted agents, radiation therapy

Diagnosed with a first invasive malignancy of leukemia, lymphoma, melanoma, sarcoma, breast, thyroid, or colorectal cancer (stage 1-3 for solid tumors) between the ages of 15-39 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 12 months

Awards & highlights

Study Summary

This trial is studying how well an interactive survivorship program works in improving healthcare resources for adolescent and young adult cancer survivors.

Who is the study for?

This trial is for young adult cancer survivors aged 18 or older who were diagnosed with leukemia, lymphoma, melanoma, sarcoma, breast, thyroid, or colorectal cancer between ages 15-39. They must be within 1-5 years of diagnosis and have finished active treatment at least 6 months ago. Participants need to understand English and have access to email and a smartphone or internet.Check my eligibility

What is being tested?

The INSPIRE-AYA study tests an interactive program designed to help adolescent and young adult cancer survivors by improving their access to healthcare resources. The goal is to enhance health literacy, self-management skills, adherence to care guidelines and reduce distress related to their past cancer experience.See study design

What are the potential side effects?

Since this trial involves informational interventions rather than medical treatments or drugs, traditional side effects are not expected. However, participants may experience emotional discomfort when discussing their cancer experiences.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have undergone treatment for my advanced disease, including surgery, chemotherapy, targeted therapy, or radiation.

Select...

I was diagnosed with my first cancer between ages 15-39.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in distress score from baseline to 12 months

Change in distress score from baseline to 3 months

Proportion of HCA-cancer surveillance (SM)

+1 more

Secondary outcome measures

Proportion of healthcare adherence (HCA)-all

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm I (INSPIRE, telehealth care)Experimental Treatment4 Interventions

Patients receive a personalized SCP and use the INSPIRE mobile application. Patients may receive telehealth stepped care after 1 month.

Group II: Arm II (control website)Active Control2 Interventions

Patients receive access to a study-specific control website that has annotated links to existing resources for AYA survivors. After 12 months, patients receive a personalized SCP and have access to the digital INSPIRE intervention program without telehealth calls.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Supportive Care

2013

Completed Phase 2

~1710

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Fred Hutchinson Cancer CenterLead Sponsor

556 Previous Clinical Trials

1,342,568 Total Patients Enrolled

18 Trials studying Sarcoma

580 Patients Enrolled for Sarcoma

National Cancer Institute (NCI)NIH

13,664 Previous Clinical Trials

40,925,305 Total Patients Enrolled

454 Trials studying Sarcoma

229,505 Patients Enrolled for Sarcoma

Fred Hutchinson Cancer Research CenterLead Sponsor

443 Previous Clinical Trials

147,545 Total Patients Enrolled

16 Trials studying Sarcoma

537 Patients Enrolled for Sarcoma

Media Library

Interactive Survivorship Program Clinical Trial Eligibility Overview. Trial Name: NCT04593277 — N/A

Sarcoma Research Study Groups: Arm I (INSPIRE, telehealth care), Arm II (control website)

Sarcoma Clinical Trial 2023: Interactive Survivorship Program Highlights & Side Effects. Trial Name: NCT04593277 — N/A

Interactive Survivorship Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT04593277 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the research team actively seeking volunteers for this project?

"Affirmative. Clinicaltrials.gov documents this medical trial, initiated on 10/23/2022, is actively seeking participants. There are 1200 patients to be enrolled from 5 sites in total."

Answered by AI

What is the current participant count for this experiment?

"The specified criteria for patient inclusion necessitates 1200 participants. Those interested in taking part can do so at the Dana-Farber Cancer Institute, located in Boston Massachusetts and/or the University of Pennsylvania/Abramson Cancer Center, situated in Philadelphia Pennsylvania."

Answered by AI

Are there a considerable number of hospitals conducting this medical experiment in the city?

"Five distinct sites have been approved to conduct this trial, including Dana-Farber Cancer Institute in Boston, University of Pennsylvania/Abramson Cancer Center in Philadelphia and Fred Hutch/University of Washington Cancer Consortium in Seattle. Additionally, there are two other centres engaged with the study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study

2022. "Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04593277.

All > Colorectal Cancer Los Angeles > Thyroid Cancer